EDIT:NASDAQ
Editas Medicine Inc
2,17 $
arrow_upward
+1,40%(+0,030) 1D
13 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,14 $
High
2,21 $
Low
2,01 $
Mkt. cap
334,92 մլն
Avg. vol.
2,42 մլն
Volume
2,79 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
2,14 $
High
2,21 $
Low
2,01 $
Mkt. cap
334,92 մլն
Avg. vol.
2,42 մլն
Volume
2,79 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
24/7 Wall St.
·
1 ժամ առաջ
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
TradingView
·
5 ժամ առաջ
SpaceX's S&P 500 bid gets new life as Elon Musk pitches Tesla merger
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc